Document Detail


Effect of angiotensinogen on blood pressure regulation in normotensive rats: application of a loss of function approach.
MedLine Citation:
PMID:  8903649     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate the effect of plasma angiotensinogen on blood pressure regulation in normotensive rats, by a loss of function approach using antisense oligonucleotides. DESIGN AND METHODS: Eight-week-old male Wistar rats were transfected with antisense, sense or scrambled oligonucleotides using liposomes containing viral agglutinins, which are reported to be highly efficient in promoting fusion with target cells. The abdomen was opened with a median incision, and the liver and portal vein were exposed. Then 2.5 ml of hemagglutinating virus-liposome complex containing oligonucleotides was introduced into the liver by multiple direct injections or infusion via the portal vein. Blood pressure, plasma angiotensinogen and angiotensin II levels were measured after transfection. The hepatic angiotensinogen level was examined by Northern blotting and radioimmunoassay. RESULTS: The in vivo injection of antisense oligonucleotides against rat angiotensinogen by the hemagglutinating virus-liposome gene transfer method into normotensive rats resulted in a transient fall in blood pressure from day 1 to day 4 after injection. This was accompanied by a decrease in plasma angiotensinogen and hepatic angiotensinogen messenger RNA levels on day 2. No significant changes were noted in untreated rats or those treated with sense or scrambled oligonucleotides. Plasma angiotensin II concentration was also reduced by antisense treatment, but not sense or scrambled treatment. CONCLUSIONS: In vivo administration of antisense angiotensinogen oligonucleotides resulted in a transient decrease in blood pressure accompanied by a decrease in plasma angiotensinogen and angiotensin II levels, which suggests that angiotensinogen plays a pivotal role in the regulation of blood pressure in normotensive rats.
Authors:
N Tomita; R Morishita; J Higaki; S Tomita; M Aoki; Y Kaneda; T Ogihara
Related Documents :
6908749 - Urinary kallikrein and hypertension in cadmium-exposed rats.
25191599 - Casein improves brachial and central aortic diastolic blood pressure in overweight adol...
10490899 - Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous me...
8319999 - Circadian blood pressure variation in transgenic hypertensive rats.
8829819 - Hypertension from carotid occlusion decreases renal papillary plasma flow, hypotension ...
20645789 - Effect of myricetin on blood pressure and metabolic alterations in fructose hypertensiv...
7973239 - Median analysis of blood pressure for a sample including treated hypertensives.
1913759 - Effect of glyceryl trinitrate on distensibility of peripheral muscular arteries in huma...
11566969 - Time-qualified reference values for ambulatory blood pressure monitoring in pregnancy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of hypertension     Volume:  13     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1997-03-19     Completed Date:  1997-03-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1767-74     Citation Subset:  IM    
Affiliation:
Department of Geriatric Medicine, Osaka University Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / blood,  drug effects
Angiotensinogen / blood*,  drug effects,  genetics
Animals
Base Sequence
Blood Pressure / physiology*
Blotting, Northern
Gene Transfer Techniques
Infusions, Intravenous
Liver / drug effects*,  metabolism
Male
Microscopy, Fluorescence
Molecular Sequence Data
Oligonucleotides, Antisense / administration & dosage*
Portal Vein
RNA, Messenger / analysis*
Rats
Rats, Wistar
Chemical
Reg. No./Substance:
0/Oligonucleotides, Antisense; 0/RNA, Messenger; 11002-13-4/Angiotensinogen; 11128-99-7/Angiotensin II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
Next Document:  Na+,K+,Cl- cotransport is a marker of distal tubular function in essential hypertension.